Sign in

CIK 0001672619 · Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811523849
Phone
650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,230,845
in 7 filings, $1.6M under 10b5-1 plans

Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hohl Benjamin −$887K CHIEF FINANCIAL OFFICER sold 32% of stake
  2. Collins Helen Louise −$737K CHIEF MEDICAL OFFICER sold 38% of stake
  3. Garland J. Scott −$607K Director sold 100% of stake

Reading 37 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-23 Patel Anish Chief Operating Officer Grant or award +36,722 36,722
2023-02-23 Patel Anish Chief Operating Officer Grant or award +394,027 394,027
2023-02-23 Patel Anish Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +10,767 10,767
2023-02-23 Patel Anish Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +2,827 2,827
2023-02-23 Patel Anish Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +75,620 75,620
2023-02-23 Lyssikatos Joseph P Chief Scientific Officer Grant or award +1,117,035 1,117,035
2023-02-23 Lyssikatos Joseph P Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +344,550 344,550
2023-02-23 Lyssikatos Joseph P Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +88,531 88,531
2023-02-23 Hohl Benjamin Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +262,120 262,120
2023-02-23 Kintz Samuel President and CEO Grant or award +1,087,525 1,087,525
2023-02-23 Kintz Samuel President and CEO Grant or award +88,531 88,531
2023-02-23 Kintz Samuel President and CEO Grant or award +88,531 88,531
2023-02-23 Kintz Samuel President and CEO Grant or award · Employee Stock Option (right to buy) +344,550 344,550
2023-02-23 Kintz Samuel President and CEO Grant or award · Employee Stock Option (right to buy) +404,363 404,363
2023-02-23 Collins Helen Louise Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +287,084 287,084
2023-02-23 RA CAPITAL MANAGEMENT, L.P. Former 10% owner Grant or award +1,152,460 2,122,465
2023-02-23 ORBIMED ADVISORS LLC Director Grant or award +7,611,458 8,661,225
2023-02-23 ORBIMED ADVISORS LLC Director Grant or award +288,114 288,114
2023-02-22 COMMODORE CAPITAL LP 10% owner Purchase +23,565 $5.11 $120K 2,872,513
2023-02-22 GRAY MICHAEL CFO & COO Sale −9,856 $4.67 $46K 27,610

Page 32 of 37 · 724 trades